Repare Therapeutics Inc. (RPTX) Tops Q2 EPS by 5c
Tweet
Share
E-mailGet Alerts RPTX Hot Sheet
Join SI Premium – FREE
Repare Therapeutics Inc. (NASDAQ: RPTX) reported Q2 EPS of ($0.82), $0.05 better than the analyst estimate of ($0.87). Revenue for the quarter came in at $1.07 million versus the consensus estimate of $2.58 million.
For earnings history and earnings-related data on Repare Therapeutics Inc. (RPTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jaguar Health (JAGX) Tops Q2 EPS by 3647c
- Accuray (ARAY) Tops Q4 EPS by 1c
- Unifi, Inc. (UFI) Misses Q4 EPS by 11c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
